ArQule (NASDAQ:ARQL) and Editas Medicine (EDIT) Financial Contrast – The Ledger Gazette
|
ArQule (NASDAQ:ARQL) and Editas Medicine (EDIT) Financial Contrast
The Ledger Gazette It is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 … |
